Bg pattern

EMGALITY 120 mg SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use EMGALITY 120 mg SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Emgality 120mg solution for injection in pre-filled syringe

galcanezumab

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Emgality and what is it used for
  2. What you need to know before you use Emgality
  3. How to use Emgality
  4. Possible side effects
  5. Storage of Emgality
  6. Contents of the pack and other information

1. What is Emgality and what is it used for

Emgality contains galcanezumab, a medicine that blocks the activity of a naturally occurring substance in the body called calcitonin gene-related peptide (CGRP). People with migraine may have increased levels of CGRP.

Emgality is used to prevent migraine in adults who have at least 4 days of migraine per month.

Emgality may reduce the frequency of migraine and improve your quality of life. It starts to work in about one week.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Emgality

Do not use Emgality:

  • if you are allergic to galcanezumab or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor, pharmacist, or nurse before or during treatment with Emgality if:

  • you have severe cardiovascular disease. Emgality has not been studied in patients with severe cardiovascular diseases.

Monitor for signs of allergic reactions

Emgality may cause potentially serious allergic reactions. Serious allergic reactions usually occur within 1 day after using Emgality, but some reactions may be delayed (occurring more than 1 day and up to 4 weeks after using Emgality). Some allergic reactions can be long-lasting. You should monitor for signs of these reactions while using Emgality. Stop using Emgality and tell your doctor or seek medical attention immediately if you notice any signs of a serious allergic reaction. These signs are listed under “Serious side effects” in section 4.

Children and adolescents

This medicine must not be given to children and adolescents under 18 years because it has not been studied in this age group.

Other medicines and Emgality

Tell your doctor, pharmacist, or nurse if you are using, have recently used, or might use any other medicines.

Pregnancy and breastfeeding

If you are a woman who could become pregnant, you are advised to avoid becoming pregnant while using Emgality.

If you are pregnant or think you may be pregnant, talk to your doctor before using this medicine. It is preferable to avoid using Emgality during pregnancy, as the effects of this medicine in pregnant women are not known.

If you are breastfeeding or plan to breastfeed, talk to your doctor before using this medicine. You and your doctor must decide whether to breastfeed or use Emgality.

Driving and using machines

Galcanezumab may have a small effect on your ability to drive and use machines. Some patients have experienced dizziness while using Emgality.

Emgality contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per 120 mg dose; it is essentially “sodium-free”.

3. How to use Emgality

Follow exactly the administration instructions for this medicine given by your doctor, pharmacist, or nurse. If you are unsure, talk to your doctor, pharmacist, or nurse again.

The Emgality pre-filled syringe is for single use and contains one dose of Emgality (120 mg).

  • The first time you are given Emgality, your doctor or nurse will inject two syringes (240 mg in total).
  • After the first dose, you will use one syringe (120 mg) every month.

Your doctor will decide how long you should use Emgality.

Emgality is given by injection under the skin (subcutaneous injection). You and your doctor or nurse must decide if you can inject Emgality yourself.

It is important that you do not try to inject yourself until you have been trained on how to do it by your doctor or nurse. A caregiver can also give you your Emgality injection if they are properly trained.

The syringe must not be shaken.

Read the “Instructions for Use” of the syringe carefully before using Emgality.

If you use more Emgality than you should

If you have injected more Emgality than you should, e.g., if after the first dose of 240 mg you have injected the medicine twice in one month, or if someone else has used Emgality accidentally, talk to your doctor immediately.

If you forget to use Emgality

Do not inject a double dose to make up for a forgotten injection.

If you have forgotten to inject a dose of Emgality, inject the missed dose as soon as possible and then inject the next dose after one month from that date.

If you stop using Emgality

Do not stop using Emgality without talking to your doctor first.

If you have any other questions about the use of this medicine, ask your doctor, pharmacist, or nurse.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Serious side effects

Generally, allergic reactions with Emgality are mild to moderate (such as rash or itching). Serious allergic reactions can occur rarely (may affect up to 1 in 1000 people) and signs may include:

  • difficulty breathing or swallowing,
  • low blood pressure, which can cause dizziness or fainting,
  • swelling of the neck, face, mouth, lips, tongue, or throat that can develop rapidly,
  • intense itching of the skin with rash or hives.

Talk to your doctor or seek medical attention immediately if you notice any of these signs.

Other side effects reported

Very common side effects(may affect more than 1 in 10 people):

  • Pain at the injection site
  • Injection site reactions (e.g., red skin, itching, bruising, swelling)

Common side effects(may affect up to 1 in 10 people):

  • Dizziness (a feeling of spinning or dizziness)
  • Constipation
  • Itching
  • Rash

Uncommon side effects(may affect up to 1 in 100 people):

  • Hives (itchy rash on the skin)

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Emgality

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The expiry date is the last day of the month shown.

Store in a refrigerator (between 2°C and 8°C). Do not freeze.

Keep the pre-filled syringe in the original package to protect it from light.

Emgality can be left outside the refrigerator for a single period of up to 7 days at a temperature not above 30°C. The syringe should be discarded if stored at a higher temperature or for a longer period.

Do not use this medicine if you notice that the syringe is damaged or the medicine appears cloudy or has particles in it.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and additional information

Composition of Emgality

  • The active substance is galcanezumab. Each pre-filled syringe contains 120 mg of galcanezumab in 1 ml of solution.
  • The other ingredients are: L-histidine, L-histidine hydrochloride monohydrate, polysorbate 80, sodium chloride, and water for injectable preparations.

Appearance and pack contents of the product

Emgality is an injectable solution in a single-dose, transparent glass syringe. Its color may vary from colorless to slightly yellow. Pack sizes of 1, 2, or 3 pre-filled syringes.

Only some pack sizes may be marketed.

Marketing authorisation holder

Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, Netherlands.

Manufacturer

Eli Lilly Italia S.p.A., Via Gramsci 731/733, 50019, Sesto Fiorentino (FI), Italy.

You can request more information about this medicine by contacting the local representative of the marketing authorisation holder:

Belgique/België/Belgien

Eli Lilly Benelux S.A./N.V.

Tél/Tel: + 32-(0)2 548 84 84

Lietuva

Eli Lilly Lietuva

Tel. +370 (5) 2649600

Text in Bulgarian language with contact information of a pharmaceutical company and phone number

Luxembourg/Luxemburg

Eli Lilly Benelux S.A./N.V.

Tél/Tel: + 32-(0)2 548 84 84

Ceská republika

ELI LILLY CR, s.r.o.

Tel: + 420 234 664 111

Magyarország

Lilly Hungária Kft.

Tel: + 36 1 328 5100

Danmark

Eli Lilly Danmark A/S

Tlf: +45 45 26 60 00

Malta

Charles de Giorgio Ltd.

Tel: + 356 25600 500

Deutschland

Lilly Deutschland GmbH

Tel. + 49-(0) 6172 273 2222

Nederland

Eli Lilly Nederland B.V.

Tel: + 31-(0) 30 60 25 800

Eesti

Eli Lilly Nederland B. V.

Tel: +372 6 817 280

Norge

Eli Lilly Norge A.S.

Tlf: + 47 22 88 18 00

Ελλάδα

ΦΑΡΜΑΣΕΡΒ-ΛΙΛΛΥ Α.Ε.Β.Ε.

Τηλ: +30 210 629 4600

Österreich

Eli Lilly Ges.m.b.H.

Tel: + 43-(0) 1 711 780

España

Organon Salud, S.L.

Tel: +34 91 591 12 79

Polska

Eli Lilly Polska Sp. z o.o.

Tel: +48 22 440 33 00

France

Organon France

Tél: +33-(0) 1 57 77 32 00

Portugal

Lilly Portugal Produtos Farmacêuticos, Lda

Tel: + 351-21-4126600

Hrvatska

Eli Lilly Hrvatska d.o.o.

Tel: +385 1 2350 999

România

Eli Lilly România S.R.L.

Tel: + 40 21 4023000

Ireland

Eli Lilly and Company (Ireland) Limited

Tel: + 353-(0) 1 661 4377

Slovenija

Eli Lilly farmacevtska družba, d.o.o.

Tel: +386 (0)1 580 00 10

Ísland

Icepharma hf.

Sími + 354 540 8000

Slovenská republika

Eli Lilly Slovakia s.r.o.

Tel: + 421 220 663 111

Italia

Eli Lilly Italia S.p.A.

Tel: + 39- 055 42571

Suomi/Finland

Oy Eli Lilly Finland Ab

Puh/Tel: + 358-(0) 9 85 45 250

Κύπρος

Phadisco Ltd

Τηλ: +357 22 715000

Sverige

Eli Lilly Sweden AB

Tel: + 46-(0) 8 7378800

Latvija

Eli Lilly (Suisse) S.A Parstavnieciba Latvija

Tel: +371 67364000

United Kingdom(Northern Ireland)

Eli Lilly and Company (Ireland) Limited

Tel: + 353-(0) 1 661 4377

Date of last revision of this leaflet:

Other sources of information

Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu/.

Instructions for use

Emgality 120mg solution for injection in pre-filled syringe

galcanezumab

For subcutaneous use

Pre-filled syringe transparent with plunger retracted and blue-green needle ready for use

Before using your pre-filled syringe:

Importantinformation

  • Your doctor or nurse should teach you how to prepare and inject Emgality using the syringe. Do not inject or inject someone else until you have been shown how to inject Emgality.
  • Keep these instructions and re-read them if you need to.
  • Each syringe is for SINGLE USE ONLY. Do not share or reuse your syringe. Otherwise, you may transmit or be infected.
  • Your doctor, pharmacist, or nurse can help you decide which area of your body to inject your dose. You can also read in these instructions the section “Choose your injection site” to help you choose which area may be best for you.
  • If you have vision problems, do not use the Emgality syringe without the help of a caregiver.

INSTRUCTIONS FOR USE

Before using the Emgality syringe, read and follow all the step-by-step instructions carefully.

Emgality syringe with blue plunger, green rod, medicine body, needle, and transparent protector labeled

Before you start

Take the syringe out of the refrigerator

Put the original package with the remaining unused syringes back in the refrigerator.

Leave the needle protector on the syringe until you are ready to inject.

Do notshake.

For a more comfortable injection, leave the syringe at room temperature for 30 minutes before injecting.

Do notput the syringe in the microwave, run hot water over it, or put it in direct sunlight.

Inspect the syringe and medicine

Make sure you have the correct medicine. The medicine inside should be clear. The color may vary from colorless to slightly yellow.

Do notuse the syringe and dispose of it as instructed by your doctor, pharmacist, or nurse if:

  • it appears damaged
  • the medicine is cloudy, discolored, or has small particles
  • the expiration date printed on the label has passed
  • the medicine is frozen

Pre-filled syringe transparent with blue plunger and black ring highlighted in red circle indicating expiration date

Prepare to inject

Wash your hands with water and soap before injecting Emgality. Make sure you have a sharps container nearby.

Choose your injection site

Your doctor, pharmacist, or nurse can help you choose the best injection site for you.

Back of the arm with overlaid text indicating injection areaHuman body diagram showing areas for medical patch application on abdomen, hip, and knees

  • You can inject the medicine into the area around your stomach (abdomen) or thigh. Do not inject into the area within 5 centimeters around your navel.
  • Someone else can inject you in the back of your arm or buttock.
  • Do not inject in the same spot as the previous time. For example, if your first injection was in your abdomen, your next injection could be in another area of your abdomen.
  • Clean and dry the injection site before injecting.

1

Remove the cap

Hand holding syringe with needle protector and other hand removing protective cap with red arrow indicating direction

  • Leave the needle protector on the syringe until you are ready to inject.
  • When you are ready to inject, remove the needle protector and throw it away.
  • Do not put the needle protector back on the syringe – this could damage the needle or cause accidental injury.
  • Do not touch the needle.

2

Insert

Hand injecting with syringe in thigh skin, 90-degree angle indicated with red lines, needle inserted and liquid visible

  • Gently pinch and hold a fold of skin at the injection site.
  • Insert the needle at a 45-degree angle.

3

Inject

Hand holding auto-injector with needle inserted in arm skin, red arrow indicating injection direction

  • Slowly push the plunger to push the plunger all the way down until all the medicine is injected.
  • The gray plunger of the syringe should move to the end of the syringe.
  • When the injection is complete, you should see the blue-green plunger rod through the syringe body.
  • Remove the needle from your skin and gently release the skin fold.
  • Do not put the needle protector back on the syringe.

White and turquoise auto-injector device held by a hand with arrows indicating parts of the mechanism

Blue-green plunger rod

Syringe gray plunger

After injecting your medicine

Dispose of the syringe

DO NOT put the needle protector back on the syringe. Dispose of the syringe in a sharps container or as instructed by your doctor, pharmacist, or nurse.

Hand holding syringe with needle over white biological waste container with hazard symbol

When disposing of the syringe and sharps container:

  • Do not recycle the filled sharps container.
  • Ask your doctor, pharmacist, or nurse how to dispose of unused medicines.

Frequently asked questions

Q.

What if I see air bubbles in my Emgality syringe?

A.

It is normal to have air bubbles in the syringe. Emgality is injected under the skin (subcutaneous injection).

Q.

What if there is a drop of liquid on the tip of the needle when I remove the needle protector?

A.

A drop of liquid on the tip of the needle is not unusual.

Q.

What do I do if I cannot push the plunger?

A.

If the plunger is stuck or damaged:

  • Do not continue using the syringe
  • Remove the needle from your skin
  • Dispose of the syringe and get a new one

Q.

What if there is a drop of liquid or blood on my skin after injection?

A.

This is normal. Press a cotton ball or gauze over the injection site. Do not rub the injection site.

Q.

How do I know when the injection is complete?

A.

Your injection is complete when:

  • The blue-green plunger rod should be visible through the syringe body.
  • The gray plunger of the syringe should have moved to the end of the syringe.

To learn more about your medicine, read the complete Emgality leaflet inside this package.

Revision date:

Online doctors for EMGALITY 120 mg SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE

Discuss questions about EMGALITY 120 mg SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (140)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for EMGALITY 120 mg SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE?
EMGALITY 120 mg SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in EMGALITY 120 mg SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE?
The active ingredient in EMGALITY 120 mg SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE is galcanezumab. This information helps identify medicines with the same composition but different brand names.
Who manufactures EMGALITY 120 mg SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE?
EMGALITY 120 mg SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE is manufactured by Eli Lilly Nederland B.V.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of EMGALITY 120 mg SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether EMGALITY 120 mg SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to EMGALITY 120 mg SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE?
Other medicines with the same active substance (galcanezumab) include EMGALITY 120 mg SOLUTION FOR INJECTION IN A PRE-FILLED PEN, AIMOVIG 140 mg SOLUTION FOR INJECTION IN A PRE-FILLED PEN, AIMOVIG 70 mg SOLUTION FOR INJECTION IN A PRE-FILLED PEN. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media